Iron deficiency in Retired Workers exposed to Mineral dust with Chronic Obstructive Pulmonary Disease
![]() |
Lee, Jong Seong
(Institute of Occupation and Environment, Korea Workers' Compensation & Welfare Service)
Shin, Jae Hoon (Institute of Occupation and Environment, Korea Workers' Compensation & Welfare Service) Baek, Jin Ee (Institute of Occupation and Environment, Korea Workers' Compensation & Welfare Service) Jeong, Ji Yeong (Institute of Occupation and Environment, Korea Workers' Compensation & Welfare Service) Kim, Hyeong Geun (Incheon Hospital, Korea Workers' Compensation & Welfare Service) Choi, Byung-Soon (Institute of Occupation and Environment, Korea Workers' Compensation & Welfare Service) |
1 | Agusti A. Thomas a. Neff lecture. Chronic obstructive pulmonary disease-a systemic disease. Proc Am Thorac Soc 2006;3:478-481. https://doi.org/10.1513/pats.200603-058MS DOI |
2 | World Health Organization(WHO). Assessing the iron status of populations: report of a joint World Health Organization/ Centers for Disease Control and Prevention technical consultation on the assessment of iron status at the population level, 2nd ed., Geneva, World Health Organization, 2007. Available from: URL:http://www.who.int/nutrition/publications/micronutrients/anaemia_iron_deficiency/9789241596107.pdf(download 2018.10.1.) |
3 | Worwood M. Serum ferritin. CRC Crit Rev Clin Lab Sci 1979;10(2):171-204(PMID:378539) DOI |
4 | Ahn J & Johnstone RM. Origin of a soluble truncated transferrin receptor. Blood 1993;81(9):2442-2451(PMID:8481524) DOI |
5 | Choi JK, Paek DM, Lee JO. Normal predictive values of spirometry in Korean population. Tuberc Respir Dis 2005;58:230-242. https://doi.org/10.4046/trd.2005.58.3.230 DOI |
6 | Balmes J, Becklake M, Blanc P, Henneberger P, Kreiss K et al. American Thoracic Society Statement: Occupational contribution to the burden of airway disease. Am J Respir Crit Care Med 2003;167(5):787-797. https://doi.org/10.1164/rccm.167.5.787 DOI |
7 | Beguin Y. Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clinica Chimica Acta 2003;329:9-22. https://doi.org/10.1016/S0009-8981(03)00005-6 DOI |
8 | Bergdahl IA, Tore'n K, Eriksson K, Hedlund U, Nilsson T et al. Increased mortality in COPD among construction workers exposed to inorganic dust. Eur Respir J 2004;23: 402-406. https://doi.org/10.1183/09031936.04.00034304 DOI |
9 | Chen YW, Leung JM, Sin DD. A Systematic Review of Diagnostic Biomarkers of COPD Exacerbation. PLoS One 2016;11(7):e0158843. https://doi.org/10.1371/journal.pone.0158843 DOI |
10 | Cloonan SM, Mumby S, Adcock IM, Choi AMK, Chung KF et al. The "Irony" of Iron Over load and Iron Deficiency in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2017;196(9):1103-1112. https://doi.org/10.1164/rccm.201702-0311PP DOI |
11 | Coggon D & Anthony Newman TA. Coal mining and chronic obstructive pulmonary disease: a review of the evidence. Thorax 1998;53:398-407(PMID:9708233) DOI |
12 | Cohen RAC, Patel A, Green FHY. Lung disease caused by exposure to coal mine and silica dust. Semin Respir Crit Care Med 2008;29:651-661. https://doi.org/10.1055/s-0028-1101275 DOI |
13 | Cook JD, Skikne BS, Baynes RD. Serum transferrin receptor. Annu Rev Med 1993;44:63-74. https://doi.org/10.1146/annurev.me.44.020193.000431 DOI |
14 | Hnizdo E, Sullivan PA, Bang KM, Wagner G. Association between Chronic Obstructive Pulmonary Disease and Employment by Industry and Occupation in the US Population: A Study of Data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2002;156(8):738-746(PMID:12370162) DOI |
15 | Drakesmith H & Prentice AM. Hepcidin and the iron-infection axis. Science 2012;338(6108):768-772. https://doi.org/10.1126/science.1224577 DOI |
16 | Fogarty AW, Jones S, Britton JR, Lewis SA, McKeever TM. Systemic inflammation and decline in lung function in a general population: a prospective study. Thorax 2007;62(6):515-520. https://doi.org/10.1136/thx.2006.066969 DOI |
17 | Gan WQ, Man SFP, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a metaanalysis. Thorax 2004;59:574-580. https://doi.org/10.1136/thx.2003.019588 DOI |
18 | Ganz T & Nemeth E. Hepcidin and disorders of iron metabolism. Annu Rev Med 2011;62:347-360. https://doi.org/10.1146/annurev-med-050109-142444 DOI |
19 | Halpern MT, Zilberberg MD, Schmier JK, Lau EC, Shorr AF. Anemia, costs and mortality in chronic obstructive pulmonary disease. Cost Eff Resour Alloc 2006;4:17. https://doi.org/10.1186/1478-7547-4-17 DOI |
20 | Jayaranee S & Sthaneshwar P. Serum soluble transferrin receptor in hypochromic microcytic anaemia. Singapore Med J 2006;47(2):138-142(PMID:16435056) |
21 | Joo H, Park J, Lee SD, Oh YM. Comorbidities of chronic obstructive pulmonary disease in Koreans: a populationbased study. J Korean Med Sci 2012;27(8):901-906. https://doi.org/10.3346/jkms.2012.27.8.901 DOI |
22 | Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R et al. Standardisation of spirometry. Eur Respir J 2005;26:319-338. https://doi.org/10.1183/09031936.05.00034805 DOI |
23 | Karadag F, Kirdar S, Karul AB, Ceylan E. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease. Eur J Intern Med 2008;19(2):104-108. https://doi.org/10.1016/j.ejim.2007.04.026 DOI |
24 | Duru S, Bilgin E, Ardic S. Hepcidin: A useful marker in chronic obstructive pulmonary disease. Ann Thorac Med 2012;7(1):31-35. https://doi.org/10.4103/1817-1737.91562 DOI |
25 | Korean academy of tuberculosis and respiratory diseases (KATRD). Guideline for COPD and asthma. Seoul: Seoul Medcus.; 2005. p. 26-27 |
26 | Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 2012;380(9859):2095-2128. https://doi.org/10.1016/S0140-6736(12)61728-0 DOI |
27 | Meijers JM, Swaen GM, Slangen JJ.Mortality of Dutch coal miners in relation to pneumoconiosis, chronic obstructive pulmonary disease, and lung function. Occup Environ Med. 1997;54(10):708-713(PMID:9404317) DOI |
28 | Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003;101(7):2461-2463. https://doi.org/:10.1182/blood-2002-10-3235 DOI |
29 | Pantopoulos K, Porwal SK, Tartakoff A, Devireddy L. Mechanisms of mammalian iron homeostasis. Biochemistry 2012;51(29):5705-5724. https://doi.org/10.1021/bi300752r DOI |
30 | Nickol AH, Frise MC, Cheng HY, McGahey A, McFadyen BM et al. A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease. BMJ Open 2015;5(7):e007911. https://doi.org/10.1136/bmjopen-2015-007911 DOI |
31 | Pepys MB & Hirschfield GM. "C-reactive protein: a critical update". J Clin Invest 2003;111(12):1805-1812. https://doi.org/10.1172/JCI18921 DOI |
32 | Portillo K, Martinez-Rivera C, Ruiz-Manzano J. Anaemia in chronic obstructive pulmonary disease. Does it really matter? Int J Clin Pract 2013;67(6):558-565. https://doi.org/10.1111/ijcp.12125 DOI |
33 | Tkacova R, Kluchova Z, Joppa P, Petrasova D, Molcanyiova A. Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD. Respir Med 2007;101(8):1670-1676. https://doi.org/10.1016/j.rmed.2007.03.005 DOI |
34 | Sarkar M, Rajta PN, Khatana J. Anemia in Chronic obstructive pulmonary disease: Prevalence, pathogenesis, and potential impact. Lung India 2015; 32(2):142-151. https://doi.org/10.4103/0970-2113.152626 DOI |
35 | Silverberg DS, Mor R, Weu MT, Schwartz D, Schwartz IF, Chernin G. Anemia and iron deficiency in COPD patients: prevalence and the effects of correction of the anemia with erythropoiesis stimulating agents and intravenous iron. BMC Pulm Med 2014;14:24. https://doi.org/10.1186/1471-2466-14-24 DOI |
36 | Strassmann R, Bausch B, Spaar A, Kleijnen J, Braendli O et al. Smoking cessation interventions in COPD: a network meta-analysis of randomised trials. Eur Respir J 2009;34:634-640. https://doi.org/10.1183/09031936.00167708 DOI |
37 | Su B, Liu T, Fan H, Chen F, Ding H, et al.. Inflammatory Markers and the Risk of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. PLoS One 2016;11(4):e0150586. https://doi.org/10.1371/journal.pone.0150586 DOI |
38 | Tandara L, Grubisic TZ, Ivan G, Jurisic Z, Tandara M et al. Systemic inflammation up-regulates serum hepcidin in exacerbations and stabile chronic obstructive pulmonary disease. Clin Biochem 2015;48(18):1252-1257. https://doi.org/10.1016/j.clinbiochem.2015.07.010 DOI |
39 | Wang J, Dong A, Liu G, Anderson GJ, Hu TY et al. Correlation of serum hepcidin levels with disease progression in hepatitis B virus-related disease assessed by nanopore film based assay. Sci Rep 2016;6:34252. https://doi.org/10.1038/srep34252 DOI |
40 | Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997;89(3):1052-1057(PMID:9028338) DOI |
![]() |